Table 4.
Clinical parameters comparison of NHL patients (HCV+ and HCV−). Unpaired Student’s t-test between HCV+ and HCV− was applied, * p-value < 0.05 as statistically significant.
| LNH HCV+ | LNH HCV− | SIGNIFICANCE | |
|---|---|---|---|
| NUM | 4 | 59 | |
| WBC | 13.62 ± 6.23 | 9.79 ± 10.61 | p-value = 0.48 |
| HGB | 12.25 ± 2.34 | 12.40 ± 1.85 | p-value = 0.87 |
| RDW | 14.45 ± 2.20 | 14.81 ± 2.65 | p-value = 0.78 |
| PLT | 311.25 ± 108.923 | 230.49 ± 107.24 | p-value = 0.15 |
| NEUT | 10.72 ± 5.15 | 5.32 ± 4.31 | * p-value = 0.01 |
| LYMPH | 1.85 ± 0.90 | 3.56 ± 9.32 | p-value = 0.71 |
| MONO | 0.91 ± 0.77 | 0.67 ± 0.87 | p-value = 0.59 |
| LMR | 38.25 ± 14.60 | 7.47 ± 74.5 | * p-value = 0.008 |
| NLR | 6.37 ± 3.79 | 4.39 ± 5.79 | p-value = 0.50 |
| PLR | 191.5 ± 93.12 | 167.84 ± 135.70 | p-value = 0.73 |
| SIRI | 6.24 ± 4.16 | 3.60 ± 8.98 | p-value = 0.56 |
| AISI | 1814.56 ± 1418.94 | 1107.97 ± 3684.1 | p-value = 0.70 |